Programme Introduction
About this programme
👩⚕️ Nursing Practice
✅ Bedside Skills
📋 Case-Based Learning
Oncology patients, particularly those with neutropenia following chemotherapy, face significantly elevated infection risk, making disciplined infection prevention practice a core part of cancer care rather than a separate concern.
Effective oncology IPC depends on consistent neutropenic precautions, careful care of central lines and other devices, and readiness to respond quickly if an infection outbreak threatens a vulnerable patient population.
TerraLeap’s Oncology IPC programme is designed for oncology nurses, haematologists, and IPC teams, covering neutropenic precautions, device care, and outbreak readiness.
The programme covers neutropenic precaution practices, safe device care for oncology patients, and structured outbreak readiness planning for vulnerable patient populations.
Bedside skill, clinical confidence — built for real nursing practice.
Programme Scope
What this programme covers
This programme covers neutropenic precautions, device care, and outbreak readiness for oncology IPC.
🛡️
Neutropenic precautions
Infection precaution practices specific to neutropenic patients.
💉
Device care
Safe care of central lines and other devices in oncology patients.
🚨
Outbreak readiness
Preparedness planning for infection outbreaks in vulnerable populations.
⚠️
Early sepsis recognition
Recognising early signs of infection in neutropenic patients.
📋
Documentation practice
Accurate recording of precaution and device care practice.
👥
Family & visitor guidance
Guiding families and visitors on infection prevention expectations.
📊
Surveillance & tracking
Monitoring infection rates in oncology patient populations.
Learning Objectives
What you will achieve
After completing this programme, learners will be able to apply neutropenic precautions, device care, and outbreak readiness practices in oncology care.
Each objective addresses a core oncology IPC competency.
01
Apply infection precaution practices specific to neutropenic patients
02
Apply safe device care practices for central lines in oncology patients
03
Apply structured outbreak readiness planning for vulnerable patient populations
04
Recognise early signs of infection in neutropenic patients
05
Accurately record precaution and device care practice
06
Guide families and visitors on infection prevention expectations
07
Monitor infection rates in oncology patient populations
Target Audience
Who can enroll
This programme is designed for oncology nurses, haematologists, and IPC teams managing infection risk in cancer care.
Whether your role is oncology nursing, haematology, or infection control, this programme strengthens coordinated oncology IPC practice.
👩⚕️
Oncology nurses applying daily neutropenic precautions
🩺
Haematologists overseeing infection risk in cancer treatment
🔬
IPC teams supporting oncology unit outbreak readiness
📚
Trainees building foundational oncology IPC knowledge
📊
Quality teams monitoring oncology infection surveillance data
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Oncology and Immunocompromised Patient IPC
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.